ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 21 filers reported holding ARCA BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,000 | +11.8% | 50,481 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -41.4% | 50,481 | -3.8% | 0.00% | – |
| Q3 2018 | $29,000 | +31.8% | 52,481 | +30.6% | 0.00% | – |
| Q2 2018 | $22,000 | +22.2% | 40,180 | +11.1% | 0.00% | – |
| Q1 2018 | $18,000 | -87.0% | 36,180 | -64.0% | 0.00% | – |
| Q4 2017 | $138,000 | +13.1% | 100,536 | -9.3% | 0.00% | – |
| Q3 2017 | $122,000 | -31.1% | 110,831 | +53.2% | 0.00% | – |
| Q2 2017 | $177,000 | -41.8% | 72,336 | -40.5% | 0.00% | – |
| Q1 2017 | $304,000 | -12.4% | 121,657 | 0.0% | 0.00% | – |
| Q4 2016 | $347,000 | -1.1% | 121,657 | 0.0% | 0.00% | – |
| Q3 2016 | $351,000 | -0.6% | 121,657 | 0.0% | 0.00% | – |
| Q2 2016 | $353,000 | -15.3% | 121,657 | 0.0% | 0.00% | – |
| Q1 2016 | $417,000 | -24.6% | 121,657 | +2.2% | 0.00% | – |
| Q4 2015 | $553,000 | -99.7% | 119,001 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $180,727,000 | – | 4,785,154 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,460,209 | $3,505,000 | 0.13% |
| Aveo Capital Partners, LLC | 93,667 | $225,000 | 0.08% |
| Tekla Capital Management LLC | 811,227 | $1,988,000 | 0.07% |
| ROYCE & ASSOCIATES LP | 179,847 | $441,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,216,840 | $2,981,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 576 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 11,018 | $26,000 | 0.00% |
| DEUTSCHE BANK AG\ | 60,308 | $144,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 16,181 | $39,000 | 0.00% |
| MORGAN STANLEY | 243 | $1,000 | 0.00% |